Monthly Archives: June 2023

Community Pharmacy England has released a summary of the quarterly meeting of the Community Pharmacy IT Group (CP ITG)  held in June 2023. IT policy development Community Pharmacy England and CP ITG have pushed for progress on IT workstreams, for example ensuring pharmacy teams have easier access to the right records at the right time. [...]

The post Pharmacy IT workstreams update published after IT group meets appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 11 June 2023) has been published and includes articles on: Calcium chloride, calcium gluconate: potential risk of underdosing with calcium gluconate in severe hyperkalaemia Non-steroidal anti-inflammatory drugs (NSAIDs): potential risks following prolonged use after 20 weeks of pregnancy Letters and [...]

The post MHRA Drug Safety Update June 2023 appeared first on Community Pharmacy England.

Pharmacy press Boots has announced it will be closing 300 pharmacies across the country over the next 12 months. We have issued the following statement in response to this news. Chief Executive Janet Morrison said: “It is no surprise to read that Boots will be continuing to consolidate a number of its stores over the next [...]

The post Boots to close 300 pharmacies over the next year appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 May 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – July 2023 appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for GLP-1 receptor agonists* used in the management of type 2 diabetes. *Annex 4 lists individual medicines affected MSN/2023/061 Tier 3 – high impact Date of issue 27th June 2023 There are very limited, intermittent supplies of all glucagon-like peptide-1 receptor agonists [...]

The post Medicine Supply Notification: GLP-1 receptor agonists* used in the management of type 2 diabetes appeared first on Community Pharmacy England.